Clinical monitoring of direct thrombin inhibitors using the ecarin clotting time

被引：16

作者：

de Denus, S

Spinler, SA

机构：

[1] Univ Sci Philadelphia, Philadelphia Coll Pharm, Philadelphia, PA 19104 USA

[2] Univ Penn, Dept Med, Cardiovasc Sect, Philadelphia, PA 19104 USA

来源：

PHARMACOTHERAPY | 2002年 / 22卷 / 04期

关键词：

D O I：

10.1592/phco.22.7.433.33673

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：433 / 435

页数：3

共 29 条

[21]

*TEX BIOT CORP GLA, 2000, ARG PACK INS

[22]

The Medicines Company, 2000, ANG BIV PACK INS

[23] USE OF A DIRECT ANTITHROMBIN, HIRULOG, IN PLACE OF HEPARIN DURING CORONARY ANGIOPLASTY [J].

TOPOL, EJ ;

BONAN, R ;

JEWITT, D ;

SIGWART, U ;

KAKKAR, VV ;

ROTHMAN, M ;

DEBONO, D ;

FERGUSON, J ;

WILLERSON, JT ;

STRONY, J ;

GANZ, P ;

COHEN, MD ;

RAYMOND, R ;

FOX, I ;

MARAGANORE, J ;

ADELMAN, B .

CIRCULATION, 1993, 87 (05) :1622-1629

[24] Argatroban and alteplase in patients with acute myocardial infarction:: The ARGAMI study [J].

Vermeer, F ;

Vahanian, A ;

Fels, PW ;

Besse, P ;

Müller, E ;

Van de Werf, F ;

Fitzgerald, D ;

Darius, H ;

Puel, J ;

Garrigou, D ;

Simoons, ML .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2000, 10 (03) :233-240

[25]

Walenga JM, 1999, SEMIN THROMB HEMOST, V25, P61

[26]

White HD, 2001, LANCET, V358, P1855

[27]

Yusuf S, 1999, LANCET, V353, P429

[28]

Yusuf S, 2002, LANCET, V359, P294

[29]

2000, CARDIOVASCULAR DIAGN

← 1 2 3 →